In a multi-year investigation surrounding Sanofi’s epilepsy drug Depakine, the charges now include France’s medicine watchdog, the National Agency for the Safety of Medicines and Health Products (ANSM). The ANSM was indicted for “negligent injuries and manslaughter” in the Depakine case.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,